Company Filing History:
1 out of 2 
1 out of 1 
1 out of 6 Years Active: 2016-2022
Title: Innovations by Il Seob Shin
Introduction
Il Seob Shin is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of medical technology, particularly in the development of innovative solutions for patient care. With a total of three patents to his name, his work focuses on enhancing the efficacy of medical treatments through advanced methodologies.
Latest Patents
Il Seob Shin's latest patents include a disposable container designed for containing patient-customized medicinal fluid. This innovative container is adapted to dispense and seal flowable materials, featuring multiple container portions that create spaces for the medicinal fluid. It also includes a bonding portion that connects the container portions and discharge portions that allow for the separation and release of the fluid. Another significant patent involves a method for manufacturing stem cells that are appropriately sized for intravascular administration. This method aims to prepare stem cells with a diameter ranging from 11-16 micrometers, ensuring that they can effectively reach target tissues when administered into a vein, thereby enhancing the efficacy of cell therapy.
Career Highlights
Throughout his career, Il Seob Shin has worked with various companies, including Rmedica Co., Ltd. His innovative approaches and dedication to improving medical technologies have positioned him as a key figure in his field. His patents reflect a commitment to advancing healthcare solutions that cater to patient-specific needs.
Collaborations
Il Seob Shin has collaborated with notable individuals in his field, including Jeong Chan Ra and Sung Keun Kang. These collaborations have likely contributed to the development and refinement of his innovative ideas and patents.
Conclusion
Il Seob Shin's contributions to medical technology through his patents demonstrate his commitment to improving patient care. His innovative solutions have the potential to significantly impact the field of medicine, particularly in the area of personalized treatment.